MEDIFAST INC — Director's Dealing 2022

Jun 21, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2022-06-16

Reporting Person: SCHLACKMAN SCOTT (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-16	Common Stock	A	1448	—	Acquired	7252	Direct

Footnotes

F1: Represents the right to receive 1,448 shares of the Issuer's common stock in connection with the payment of the reporting person's annual director fees, which fees have been deferred under the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). These shares are granted from the Issuer's 2012 Share Incentive Plan and will vest in full on June 16, 2023.